Old Web
English
Sign In
Acemap
>
authorDetail
>
Anna Rudvik
Anna Rudvik
AstraZeneca
Type 2 diabetes
Pharmacology
Medicine
Basal (phylogenetics)
Molecular biology
3
Papers
70
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
EFFICACY, SAFETY AND TOLERABILITY OF THE 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITOR AZD5718 IN PATIENTS WITH RECENT MYOCARDIAL INFARCTION: A PHASE 2A STUDY (FLAVOUR)
2021
Journal of the American College of Cardiology
Eva Prescott
Oskar Angerås
David Erlinge
Erik Lerkevang Grove
Marja Hedman
Lisette Okkels-Jensen
John Pernow
Antti Saraste
Axel Åkerblom
Anna Rudvik
Eva-Lotte Lindstedt
Pavlo Garkaviy
Li-Ming Gan
Anders Gabrielsen
Show All
Source
Cite
Save
Citations (0)
Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes
2019
Nature Communications
Li-Ming Gan
Maria Lagerström-Fermér
Leif Carlsson
Cecilia Arfvidsson
Ann-Charlotte Egnell
Anna Rudvik
Magnus Kjaer
Anna Collén
James D. Thompson
John Joyal
Ligia Chialda
Thomas Koernicke
Rainard Fuhr
Kenneth R. Chien
Regina Fritsche-Danielson
Show All
Source
Cite
Save
Citations (56)
Evaluation of surrogate measures of insulin sensitivity - correlation with gold standard is not enough
2018
BMC Medical Research Methodology
Anna Rudvik
Marianne Månsson
Show All
Source
Cite
Save
Citations (14)
1